The weight-loss drug boom has become one of the internet’s biggest scams
CNBC December 8, 2024
Key Points
– Eli Lilly and Novo Nordisk continue to ramp production facilities and capacity for booming weight-loss drugs like Wegovy and Zepbound, with Lilly this week announcing a $3 billion investment to increase obesity drug production at a Wisconsin plant.
– But supply and demand issues have led to a boom in pharmaceutical cybercrime, with cybersecurity firm McAfee’s Threat Research Team tracking a continued rise throughout 2024 in malicious websites, scam emails and texts, posts on social media and online marketplace listings.
– Consumers are flocking to TikTok and other social media platforms and websites to purchase branded and illicit GLP-1s, often without a prescription.
One interpretation of the law of supply and demand is that when demand outstrips...